Lincomycin hydrochloride

This classification denotes a lincosamide antibiotic with the molecular formula C18H34N2O6S.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M6T05Z2B68, chemically known as lincolnensin, hydrochloride, hemihydrate but more generally known as lincomycin hydrochloride, which bears US NIH Compound Identifier 3928. European Medicines Agency schedules Lincomycin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02924MIG. Most nations, for tariff and trade purposes, schedule lincomycin hydrochloride under HS 29419000 and SITC 54139. As of Q4 2014, LINCOMYCIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Lincomycin hydrochloride bears US NLM identifiers UMLS ID C0282219 and NCI Concept Code C66013. SMILES: CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O.O.CL.